Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus- acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type B vaccines administered to infants primed at birth with hepatitis B vaccine

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 3, 2004, Pages 685-692

  Heng, Kock Cheng ^a   Rajadurai, V S ^a   Amin, Z ^a   Sriram, B ^a   Yee, M F ^a   Han, H H ^b   Bock, H L ^b   Safary, A ^b  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG SAFETY; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFANT; NORMAL HUMAN; PERTUSSIS; POLIOMYELITIS VIRUS; RANDOMIZED CONTROLLED TRIAL; TEMPERATURE MEASUREMENT; TETANUS; VACCINATION;

EID: 8444236056     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. American Academy of Pediatrics, Committee on Infectious Diseases. Recommended childhood immunization schedule -United States January-December 1999. Pediatrics 1999; 103: 182-5.
2. Avis du Conseil Superieur d'Hygiene Publique de France du 13 mars 1998. Bull Epidémiol Hebdomad 1998; 15: 61-3.
3. Brown F, Greco D, Mastrantonio P, Salmaso S, Wassilak S. Pertussis vaccine trials. Session IV: vaccine efficacy. Dev Biol Stand 1997; 89: 121-93.
4. Chang MH, Chen CJ, Lau MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 1855-9.
5. Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996; 276: 906-8.
6. Dagan R, Amir J, Ashkenazi S, Hardt K, Kaufuold A. Early responses to nonconjugated polyribosylribitol phosphate challenge as evidence of immune memory after combined diphtheria-tetanus-pertussis-polio-Haemophilus influenzae type b primary vaccination. Pediatr Infect Dis J 2001; 20: 587-92.
7. Da Villa G, Picciottoc L, Elia S, Peluso F, Montanaro F, Maisto T. Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups: A comparison in the field. Vaccine 1995; 13: 1240-3.
8. Decker MD, Edwards KM, Steinhoff MC, et al. Comparison of 13 acellular vaccines: adverse reactions. Pediatrics 1995; 96: 557-66.
9. Eskola J, Oleander RM, Hovi T, Litmanen L, Peltola S, Kayhty H. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 1996; 348: 1688-92.
10. Gylca R, Gylca V, Benes O, et al. A new DTPa -HBV -IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/ Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth. Vaccine 2001; 19: 825-33.
11. Halperin SA, King J, Law B, Mills E, Willems P. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Clin Infect Dis 1999; 28: 995-1001.
12. Helwig H, Mertsola J, Harvey D, et al. Childhood immunisation in the European Union. Eur J Pediatr 1998; 157: 676-80.
13. Kane M. Hepatitis B control through immunization. In: Rizzetto M, Purcell R, Gerin JL, Verme G, eds. Viral hepatitis and liver disease. Turin: Edizioni: Minerva Medica, 1997: 638-42.
14. Poolman J, Kaufhold A, De Grave D, Goldblatt D. Clinical relevance of lower Hib response in DTPa-based combination vaccines. Vaccine 2001; 19: 2280-5.
15. Richie E, Punjabi NH, Harjanto SJ, et al. Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children. Vaccine 1999; 17: 1384-93.
16. Schmitt HJ, Schuind A, Knuf M, et al. Clinical experience of a tricomponent acellular pertussis vaccine combined with diptheria and tetanus toxoids for primary vaccination in 22,505 infants. J Pediatr 1996; 129: 695-701.
17. Schmitt HJ, Knuf M, Ortiz E, Sanger R, Uwamwezi MC, Kaufuold A. Primary vaccination of infants with diptheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. J Pediatr 2000; 137: 304-12.
18. Schmitt HJ, von Kries R, Hassenpflug B, et al. Haemophilus influenzae type B disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (inactivated poliovirus)/Haemophilus injluenzae type B combination vaccines. Pediatr Infect Dis J 2001: 767-74.
19. World Health Organization (WHO). Expanded programme on immunization. Hepatitis B control through immunisation. Global programme for vaccine and immunisation sub-committee meetings of the scientific advisory group of experts (SAGE); Geneva, June 12-16, 1995.
20. WHO. Vaccines and biologicals annual report, 1998. Geneva: World Health Organization, 1999.
21. Zepp F, Schmitt HJ, Kaufhold A, et al. Evidence for induction of polysaccharide specific B-cell-memory in the first year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DPTa-HBV combined vaccine. Eur J Pediatr. 1997; 156: 18-24.